NEW YORK (GenomeWeb News) – Purdue University has received a $1 million grant from the W.M. Keck Foundation to develop technologies to alter epigenetic marks in the genome that turn genes on and off.

The research, the university said, may result in new ways of treating genetic diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.